Monoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer
Clinical trial NCT00625586 · TERMINATED
Trial details
- NCT number
- NCT00625586
- Sponsor
- MacroGenics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-15
- Primary completion
- 2009-01-21
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.